Abstract
TAS-102 is an oral fluoropyrimidine prodrug composed of trifluridine (FTD) and tipiracil hydrochloride (TPI) in a 1:0.5 ratio. FTD is a thymidine analog, and it is degraded by thymidine phosphorylase (TP) to the inactive trifluoromethyluracil (FTY) metabolite. TPI inhibits degradation of FTD by TP, increasing systemic exposure to FTD. Patients with advanced solid tumors (6 M/2 F; median age 58 years; PS 0-1) were enrolled on this study. Patients in group A (N = 4) received 60 mg TAS-102 with 200 nCi [(14)C]-FTD, while patients in group B (N = 4) received 60 mg TAS-102 with 1000 nCi [(14)C]-TPI orally. Plasma, blood, urine, feces, and expired air (group A only) were collected up to 168 h and were analyzed for (14)C by accelerator mass spectrometry and analytes by LC-MS/MS. FTD: 59.8% of the (14)C dose was recovered: 54.8% in urine mostly as FTY and FTD glucuronide isomers. The extractable radioactivity in the pooled plasma consisted of 52.7% FTD and 33.2% FTY. TPI: 76.8% of the (14)C dose was recovered: 27.0% in urine mostly as TPI and 49.7% in feces. The extractable radioactivity in the pooled plasma consisted of 53.1% TPI and 30.9% 6-HMU, the major metabolite of TPI. Absorbed (14)C-FTD was metabolized and mostly excreted in ur...Continue Reading
References
Apr 15, 1988·Biomedical & Environmental Mass Spectrometry·Y GhoosM Hiele
Mar 1, 1981·Clinical Pharmacology and Therapeutics·R A HamiltonB J Kline
Jan 1, 1993·Life Sciences·L Z BenetE T Lin
Sep 30, 1999·Life Sciences·H GeorgesF Lapicque
Feb 24, 2001·Life Sciences·M Wang, R G Dickinson
May 22, 2002·Therapeutic Drug Monitoring·Maria ShipkovaUNKNOWN German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients
Aug 14, 2002·Biopharmaceutics & Drug Disposition·Panteha KhaliliLeonard I Wiebe
Oct 19, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Franck DesmoulinRobert Martino
Jan 25, 2006·Clinical Pharmacokinetics·Jan H BeumerJan H M Schellens
Aug 12, 2006·Cancer·David S HongPaulo M Hoff
Mar 10, 2007·Investigational New Drugs·J H BeumerJ H M Schellens
Apr 20, 2007·Cancer Science·Olaf H TemminkGodefridus J Peters
Jun 6, 2008·Investigational New Drugs·Michael J OvermanJames L Abbruzzese
Sep 18, 2008·Cancer Investigation·Michael J OvermanJames L Abbruzzese
Apr 1, 2007·Drug Metabolism Letters·F DesmoulinM Malet-Martino
Jan 8, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Lian ZhouRamaswamy A Iyer
Apr 20, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jianyao WangRasmy Talaat
May 24, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Richard A GrahamCornelis E C A Hop
Jun 28, 2012·British Journal of Cancer·T DoiT Sasaki
Sep 7, 2012·The Lancet Oncology·Takayuki YoshinoAtsushi Ohtsu
Oct 9, 2012·Journal of Proteomics·Adriana ArizaDolores Pérez-Sala
Mar 2, 2013·Chemical Research in Toxicology·Xiaoli MengB Kevin Park
Mar 22, 2014·The Journal of Biological Chemistry·Jan Terje AndersenJason Cameron
Jun 7, 2014·The Journal of Pharmacology and Experimental Therapeutics·Thomas G HammondDominic P Williams
Sep 19, 2014·Oncology Reports·Nozomu TanakaKenichi Matsuo
May 15, 2015·The New England Journal of Medicine·Robert J MayerUNKNOWN RECOURSE Study Group
Citations
May 18, 2016·Drug Metabolism Reviews·C M NijenhuisJ H Beijnen
Oct 12, 2016·Chemical Research in Toxicology·Heather A EnrightKenneth W Turteltaub
Jan 11, 2017·Journal of Clinical Pharmacology·Carlos R BecerraDaniel Von Hoff
Jan 11, 2019·British Journal of Clinical Pharmacology·Muhammad Wasif SaifRobert Winkler
Sep 7, 2019·Drugs·Connie KangEmma D Deeks
Aug 29, 2016·Drugs·Celeste B Burness, Sean T Duggan
Oct 22, 2017·Biopharmaceutics & Drug Disposition·Koichi TakahashiIkumi Tamai
Jul 31, 2019·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Betty M ChanHeinz-Josef Lenz
Apr 21, 2020·Drug Design, Development and Therapy·Nadda Muhamad, Kesara Na-Bangchang
Dec 11, 2020·Arteriosclerosis, Thrombosis, and Vascular Biology·Adam BelcherWei Li
Mar 6, 2021·Pharmacology & Therapeutics·Sakti ChakrabartiAmit Mahipal
Jan 14, 2021·Japanese Journal of Clinical Oncology·Takayuki YoshinoKei Muro
Jun 8, 2021·Cancer Chemotherapy and Pharmacology·Muhammad Wasif SaifLee Rosen